Elkfork Partners LLC Buys New Position in Smith & Nephew plc (SNN)

Elkfork Partners LLC bought a new stake in Smith & Nephew plc (NYSE:SNN) during the fourth quarter, HoldingsChannel.com reports. The firm bought 12,796 shares of the medical equipment provider’s stock, valued at approximately $448,000.

Other hedge funds also recently bought and sold shares of the company. Parametric Portfolio Associates LLC raised its stake in shares of Smith & Nephew by 17.2% during the third quarter. Parametric Portfolio Associates LLC now owns 516,794 shares of the medical equipment provider’s stock valued at $18,811,000 after purchasing an additional 76,003 shares in the last quarter. Bank of Montreal Can raised its stake in shares of Smith & Nephew by 1,088.9% during the fourth quarter. Bank of Montreal Can now owns 281,224 shares of the medical equipment provider’s stock valued at $9,846,000 after purchasing an additional 257,569 shares in the last quarter. Sei Investments Co. raised its stake in shares of Smith & Nephew by 1.8% during the fourth quarter. Sei Investments Co. now owns 131,946 shares of the medical equipment provider’s stock valued at $4,619,000 after purchasing an additional 2,371 shares in the last quarter. BTIM Corp. raised its stake in shares of Smith & Nephew by 13.6% during the fourth quarter. BTIM Corp. now owns 90,880 shares of the medical equipment provider’s stock valued at $3,182,000 after purchasing an additional 10,880 shares in the last quarter. Finally, Cambiar Investors LLC raised its stake in shares of Smith & Nephew by 10.0% during the fourth quarter. Cambiar Investors LLC now owns 5,935,389 shares of the medical equipment provider’s stock valued at $207,798,000 after purchasing an additional 537,369 shares in the last quarter. Institutional investors own 6.89% of the company’s stock.

How to Become a New Pot Stock Millionaire

A number of equities research analysts recently weighed in on the stock. Canaccord Genuity restated a “buy” rating and set a $45.00 price objective on shares of Smith & Nephew in a research note on Friday, January 5th. ValuEngine cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, February 9th. Zacks Investment Research upgraded shares of Smith & Nephew from a “sell” rating to a “hold” rating in a research note on Wednesday, February 7th. HSBC upgraded shares of Smith & Nephew from a “hold” rating to a “buy” rating in a research note on Monday, March 26th. Finally, JPMorgan Chase upgraded shares of Smith & Nephew from a “neutral” rating to an “overweight” rating in a research note on Thursday, January 25th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $44.00.

NYSE:SNN opened at $38.15 on Monday. The stock has a market cap of $16,685.21, a P/E ratio of 20.08, a PEG ratio of 2.25 and a beta of 0.72. Smith & Nephew plc has a 52-week low of $30.73 and a 52-week high of $40.43. The company has a current ratio of 2.03, a quick ratio of 1.06 and a debt-to-equity ratio of 0.31.

The company also recently announced a None dividend, which will be paid on Wednesday, May 9th. Investors of record on Friday, April 6th will be issued a dividend of $0.444 per share. The ex-dividend date of this dividend is Thursday, April 5th. Smith & Nephew’s payout ratio is currently 32.11%.

ILLEGAL ACTIVITY WARNING: This news story was first posted by WKRB News and is the property of of WKRB News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.wkrb13.com/2018/04/02/elkfork-partners-llc-buys-new-position-in-smith-nephew-plc-snn.html.

Smith & Nephew Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN).

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply